APC and colorectal carcinoma: Recently, a study has analyzed the clinical characterizes and gene mutations in APC-mutant type and APC-wild-type Chinese CRC patients and confirms that APC mutation can be used as a promising biomarker to predict the immunotherapy responsiveness (Feng et al., 2022b).